Skip to content

Prevalence of Hyperuricemia in Pakistan

Prevalence of Hyperuricemia in Pakistan

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03473444
Enrollment
1000
Registered
2018-03-22
Start date
2018-03-01
Completion date
2018-04-15
Last updated
2018-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperuricemia

Keywords

uric acid, prevalence, pakistan

Brief summary

The prevalence of hyperuricemia has rarely been investigated in developing countries Hyperuricemia, or raised serum uric acid (SUA), is the condition closely associated with gout due to the deposition of monosodium urate crystals in peripheral joints and soft tissues. Hyperuricemia is associated with an increased risk for incident hypertension, independent of traditional hypertension risk factors. This risk appears more pronounced in younger individuals and women. Cross-sectional studies show an association of hyperuricemia with the presence of CKD. Insulin resistance plays a potentially key role in the causal relationship between metabolic syndrome, type 2 Diabetes and hyperuricemia. Furthermore, it is likely that hyperuricemia and insulin resistance share a bidirectional causal effect. The rationale of this study is to determine prevalence of hyperuricemia in Pakistan.

Detailed description

Informed consent will be obtained from all patients and their attendant coming to clinics. Those who will agree to be part of this study were asked a questionnaire about co-morbidity and symptoms. Uric acid levels will be assessed by using UASure Blood Uric Acid Monitoring System. Male with uric acid levels greater than 7 mg/dl and female greater than 6 mg/dl were classified as hyperuricemia.

Interventions

None listed

Sponsors

OBS Pakistan
Lead SponsorINDUSTRY

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Informed Consent given

Exclusion criteria

* No Informed consent provided

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of Hyperuricemia4 weeksTo find out the frequency uric acid levels in Pakistani general population

Countries

Pakistan

Contacts

Primary ContactFaizan Shaukat
faizan.shaukat@obs.com.pk+923328814816

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026